6LD0
| Structure of Bifidobacterium dentium beta-glucuronidase complexed with C6-hexyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-2-hexyl-4,5-bis(oxidanyl)piperidine-3-carboxylic acid, LacZ1 Beta-galactosidase | 著者 | Lin, H.-Y, Hsieh, T.-J, Lin, C.-H. | 登録日 | 2019-11-20 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.901 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LDB
| Structure of Bifidobacterium dentium beta-glucuronidase complexed with uronic isofagomine | 分子名称: | (3S,4R,5R)-4,5-dihydroxypiperidine-3-carboxylic acid, LacZ1 Beta-galactosidase | 著者 | Lin, H.-Y, Hsieh, T.-J, Lin, C.-H. | 登録日 | 2019-11-20 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.651 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LD6
| |
6LEM
| Structure of E. coli beta-glucuronidase complex with C6-nonyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-2-nonyl-4,5-bis(oxidanyl)piperidine-3-carboxylic acid, Beta-D-glucuronidase | 著者 | Lin, H.-Y, Kuo, Y.-H, Lin, C.-H. | 登録日 | 2019-11-25 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (3.188 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LEG
| Structure of E. coli beta-glucuronidase complex with uronic isofagomine | 分子名称: | (3S,4R,5R)-4,5-dihydroxypiperidine-3-carboxylic acid, Beta-D-glucuronidase | 著者 | Lin, H.-Y, Kuo, Y.-H, Lin, C.-H. | 登録日 | 2019-11-25 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.603 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LDD
| Structure of Bifidobacterium dentium beta-glucuronidase complexed with C6-propyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-4,5-bis(oxidanyl)-2-propyl-piperidine-3-carboxylic acid, LacZ1 Beta-galactosidase | 著者 | Lin, H.-Y, Hsieh, T.-J, Lin, C.-H. | 登録日 | 2019-11-20 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.205 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LEJ
| Structure of E. coli beta-glucuronidase complex with C6-propyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-4,5-bis(oxidanyl)-2-propyl-piperidine-3-carboxylic acid, Beta-D-glucuronidase | 著者 | Lin, H.-Y, Kuo, Y.-H, Lin, C.-H. | 登録日 | 2019-11-25 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.617 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LEL
| Structure of E. coli beta-glucuronidase complex with C6-hexyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-2-hexyl-4,5-bis(oxidanyl)piperidine-3-carboxylic acid, Beta-D-glucuronidase | 著者 | Lin, H.-Y, Kuo, Y.-H, Lin, C.-H. | 登録日 | 2019-11-25 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.498 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
6LDC
| Structure of Bifidobacterium dentium beta-glucuronidase complexed with C6-nonyl uronic isofagomine | 分子名称: | (2~{S},3~{S},4~{R},5~{R})-2-nonyl-4,5-bis(oxidanyl)piperidine-3-carboxylic acid, LacZ1 Beta-galactosidase | 著者 | Lin, H.-Y, Hsieh, T.-J, Lin, C.-H. | 登録日 | 2019-11-20 | 公開日 | 2021-01-27 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (2.181 Å) | 主引用文献 | Entropy-driven binding of gut bacterial beta-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol, 4, 2021
|
|
1CSP
| |
6LVS
| |
1D1I
| |
4Y20
| |
4Y1X
| |
4Y1V
| |
4Y1U
| |
4Y26
| |
4Y22
| |
4Y1Z
| |
4Y1Y
| |
8J8W
| Crystal structure of AtHPPD-Y19788 complex | 分子名称: | 2,5-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-phenyl-quinazolin-4-one, 4-hydroxyphenylpyruvate dioxygenase, COBALT (II) ION | 著者 | Lin, H.-Y, Dong, J, Yang, G.-F. | 登録日 | 2023-05-02 | 公開日 | 2024-05-08 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.601 Å) | 主引用文献 | Crystal structure of AtHPPD-Y19788 complex To Be Published
|
|
8J8X
| Crystal structure of AtHPPD-YH20307 complex | 分子名称: | 4-hydroxyphenylpyruvate dioxygenase, 5-(1,3-dimethyl-5-oxidanyl-pyrazol-4-yl)carbonyl-1,4-dimethyl-3-propan-2-yl-benzimidazol-2-one, COBALT (II) ION | 著者 | Lin, H.-Y, Dong, J, Yang, G.-F. | 登録日 | 2023-05-02 | 公開日 | 2024-05-08 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (1.598 Å) | 主引用文献 | Crystal structure of AtHPPD-YH20307 complex To Be Published
|
|
5HLV
| Crystal structure of calcium and zinc-bound human S100A8 in space group P212121 | 分子名称: | ACETATE ION, CALCIUM ION, CHLORIDE ION, ... | 著者 | Lin, H, Andersen, G.R, Yatime, L. | 登録日 | 2016-01-15 | 公開日 | 2016-06-08 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Crystal structure of human S100A8 in complex with zinc and calcium. Bmc Struct.Biol., 16, 2016
|
|
5YWG
| Crystal structure of Arabidopsis thaliana HPPD complexed with Mesotrione | 分子名称: | 2-[(4-methylsulfonyl-2-nitro-phenyl)-oxidanyl-methylidene]cyclohexane-1,3-dione, 4-hydroxyphenylpyruvate dioxygenase, COBALT (II) ION | 著者 | Lin, H.Y, Yang, W.C. | 登録日 | 2017-11-29 | 公開日 | 2019-01-16 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.603 Å) | 主引用文献 | Molecular insights into the mechanism of 4-hydroxyphenylpyruvate dioxygenase inhibition: enzyme kinetics, X-ray crystallography and computational simulations. FEBS J., 286, 2019
|
|
5HLO
| Crystal structure of calcium and zinc-bound human S100A8 in space group C2221 | 分子名称: | ACETATE ION, CACODYLATE ION, CALCIUM ION, ... | 著者 | Lin, H, Andersen, G.R, Yatime, L. | 登録日 | 2016-01-15 | 公開日 | 2016-06-08 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | Crystal structure of human S100A8 in complex with zinc and calcium. Bmc Struct.Biol., 16, 2016
|
|